Placebo‐controlled crossover assessment of mecasermin for the treatment of Rett syndrome
In O'Leary et al. (2018)1, in the original publication, Chi‐Sang Poon was omitted from the author byline. Dr. Poon is affiliated with the Institute for Medical Engineering and Science, Massachusetts Institute of Technology, in Cambridge, Massachusetts. Dr. Poon's author contribution was primarily data analyses, and he has no conflicts of interest to declare. The correct byline is below:
Heather M. O'Leary, Walter E. Kaufmann, Katherine V. Barnes, Kshitiz Rakesh, Kush Kapur, Daniel C. Tarquinio, Nicole G. Cantwell, Katherine J. Roche, Suzanne A. Rose, Alexandra C. Walco, Natalie M. Bruck, Grace A. Bazin, Ingrid A. Holm, Mark E. Alexander, Lindsay C. Swanson, Lauren M. Baczewski, Chi‐Sang Poon, Juan M. Mayor Torres, Charles A. Nelson III, Mustafa Sahin
Additionally, the authors wish to acknowledge funding from NIH grants R03 HD082561 and R01 NS094178, which were inadvertently omitted from the Acknowledgments.
The authors apologize for these errors.
Reference
- 1. O'Leary HM, Kaufmann WE, Barnes KV, et al. Placebo‐controlled crossover assessment of mecasermin for the treatment of Rett syndrome. Ann Clin Transl Neurol 2018;5:323–332. [DOI] [PMC free article] [PubMed] [Google Scholar]